Malignant pleural effusion: current understanding and therapeutic approach.
Gonnelli F, Hassan W, Bonifazi M, Pinelli V, Bedawi EO, Porcel JM, Rahman NM, Mei F.
Respir Res. 2024 Jan 19;25(1):47. doi: 10.1186/s12931-024-02684-7.
Malignant Pleural Effusion and Its Current Management: A Review.
Skok K, Hladnik G, Grm A, Crnjac A.
Medicina (Kaunas). 2019 Aug 15;55(8):490. doi: 10.3390/medicina55080490.
Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.
Feller-Kopman DJ, Reddy CB, DeCamp MM, Diekemper RL, Gould MK, Henry T, Iyer NP, Lee YCG, Lewis SZ, Maskell NA, Rahman NM, Sterman DH, Wahidi MM, Balekian AA.
Am J Respir Crit Care Med. 2018 Oct 1;198(7):839-849. doi: 10.1164/rccm.201807-1415ST.
Single-cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non-small-cell lung cancer.
Zhang X, Wang X, Wen Y, Chen S, Zhou C, Wu F.
Clin Transl Med. 2024 Apr;14(4):e1649. doi: 10.1002/ctm2.1649.
Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.
Liu Y, Wang L, Song Q, Ali M, Crowe WN, Kucera GL, Hawkins GA, Soker S, Thomas KW, Miller LD, Lu Y, Bellinger CR, Zhang W, Habib AA, Petty WJ, Zhao D.
Nat Nanotechnol. 2022 Feb;17(2):206-216. doi: 10.1038/s41565-021-01032-w. Epub 2021 Dec 16.
Malignant pleural effusion.
Egan AM, McPhillips D, Sarkar S, Breen DP.
QJM. 2014 Mar;107(3):179-84. doi: 10.1093/qjmed/hct245. Epub 2013 Dec 24.
ERS/EACTS statement on the management of malignant pleural effusions.
Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, Scherpereel A, Rahman NM, Cardillo G, Maskell NA.
Eur Respir J. 2018 Jul 27;52(1):1800349. doi: 10.1183/13993003.00349-2018. Print 2018 Jul.
[Malignant pleural effusion].
Fjællegaard K, Petersen JK, Armbruster K, Jensen HK, Skaarup SH, Laursen CB, Clementsen PF, Bødtger U.
Ugeskr Laeger. 2021 Apr 26;183(17):V10200751.
Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO.
Cochrane Database Syst Rev. 2020 Apr 21;4(4):CD010529. doi: 10.1002/14651858.CD010529.pub3.
Differentiation of malignant from benign pleural effusions based on artificial intelligence.
Wang S, Tan X, Li P, Fan Q, Xia H, Tian S, Pan F, Zhan N, Yu R, Zhang L, Duan Y, Xu J, Ma Y, Chen W, Li Y, Zhao Z, Liu C, Bao Q, Yang L, Jin Y.
Thorax. 2023 Apr;78(4):376-382. doi: 10.1136/thorax-2021-218581. Epub 2022 Sep 30.
